These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9526953)

  • 1. The molecular markers of hemostatic activation on coronary artery disease.
    Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
    Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation as an acute effect of cigarette smoking.
    Kimura S; Nishinaga M; Ozawa T; Shimada K
    Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemostasis activation markers in acute renal failure.
    Stefanidis I; Frank D; Maurin N
    Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
    Wagner WR; Johnson PC; Thompson KA; Marrone GC
    Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.
    Wada H; Mori Y; Kaneko T; Wakita Y; Nakase T; Minamikawa K; Ohiwa M; Tamaki S; Tanigawa M; Kageyama S
    Am J Hematol; 1993 Oct; 44(2):112-6. PubMed ID: 8266915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation.
    Shinohara H; Fukuda N; Soeki T; Takeichi N; Yui Y; Tamura Y; Oki T
    Jpn Heart J; 1998 Nov; 39(6):721-30. PubMed ID: 10089934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
    Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic markers in ischemic stroke of undetermined etiology.
    Ince B; Bayram C; Harmanci H; Ulutin T
    Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coagulation system is activated in idiopathic cardiomyopathy.
    Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
    J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein(a) and hemostasis activation markers in angina pectoris].
    Tsakiris DA; Riesen WF; Marbet GA
    Dtsch Med Wochenschr; 1995 Aug; 120(33):1109-13. PubMed ID: 7656834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular marker for hemostasis and thrombosis].
    Fukutake K; Fujimaki M
    Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.